ISIN | CH0506063244 |
---|---|
Valor Number | 50606324 |
Bloomberg Global ID | |
Fund Name | UBAM (CH) - Swiss Equity en liquidation I |
Fund Provider |
Union Bancaire Privée, UBP SA
Genève 1, Switzerland Phone: +41 22 819 28 00 E-Mail: ubpfunds@ubp.com Web: www.ubp.com |
Fund Provider | Union Bancaire Privée, UBP SA |
Representative in Switzerland | |
Distributor(s) |
Banque Cantonale Vaudoise Lausanne Phone: +41 21 212 10 00 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The Swiss Equity sub-fund aims in the medium term, to generate superior returns relative to the Swiss equity market as measured by the SPI® index. The sub-fund is actively managed and the companies are chosen after a rigorous and diverse selection process. No guarantee can be given as to the achievement of the sub-fund's investment objective. |
Peculiarities |
Current Price * | 0.00 CHF | 19.09.2025 |
---|---|---|
Previous Price * | 0.00 CHF | 03.07.2025 |
52 Week High * | 0.00 CHF | 03.03.2025 |
52 Week Low * | 0.00 CHF | 09.04.2025 |
NAV * | 0.00 CHF | 19.09.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 143,094 | |
Unit/Share Assets *** | 107,683 | |
Trading Information SIX |
YTD Performance | +5.30% |
31.12.2024 - 19.09.2025
31.12.2024 19.09.2025 |
---|---|---|
1 month | 0.00% |
19.09.2025 - 19.09.2025
19.09.2025 19.09.2025 |
3 months | +0.26% |
19.06.2025 - 19.09.2025
19.06.2025 19.09.2025 |
6 months | -2.78% |
19.03.2025 - 19.09.2025
19.03.2025 19.09.2025 |
1 year | +0.67% |
19.09.2024 - 19.09.2025
19.09.2024 19.09.2025 |
2 years | +14.89% |
19.09.2023 - 19.09.2025
19.09.2023 19.09.2025 |
3 years | +22.32% |
20.09.2022 - 19.09.2025
20.09.2022 19.09.2025 |
5 years | +15.07% |
22.09.2020 - 19.09.2025
22.09.2020 19.09.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Roche Holding AG | 0.90% | |
---|---|---|
Nestle SA | 0.86% | |
Novartis AG Registered Shares | 0.71% | |
ABB Ltd | 0.57% | |
UBS Group AG Registered Shares | 0.54% | |
Zurich Insurance Group AG | 0.50% | |
Swiss Re AG | 0.35% | |
Lonza Group Ltd | 0.30% | |
Alcon Inc | 0.30% | |
Sika AG | 0.25% | |
Last data update | 30.06.2025 |
TER | 0.90% |
---|---|
TER date | 30.04.2025 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.00% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 30.06.2025 |